Sarepta Therapeutics, Inc.
215 First Street
Cambridge, MA -2142
United States
885 articles about Sarepta Therapeutics, Inc.
-
AVI BioPharma, Inc. to Raise $20.3 Million in Registered Direct Offering
12/13/2007
-
AVI BioPharma, Inc. Receives Fast Track Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
12/3/2007
-
AVI BioPharma, Inc. to Present on NEUGENE Countermeasures to Biological Threats at U.S. Department of Defense 2007 Biodefense Research Conference
11/6/2007
-
AVI BioPharma, Inc. Announces Third Quarter Financial Results
11/6/2007
-
AVI BioPharma, Inc. President and COO to Speak at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
11/5/2007
-
AVI BioPharma, Inc. Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
11/1/2007
-
AVI BioPharma, Inc. Announces 2007 Third Quarter Financial Results Conference Call
10/31/2007
-
AVI BioPharma, Inc. Announces Changes to Its Board of Directors
10/30/2007
-
AVI BioPharma, Inc. Provides Update on Clinical Trial for Treatment of Duchenne Muscular Dystrophy
10/26/2007
-
AVI BioPharma, Inc. Announces Intention to Restate Financial Statements
10/25/2007
-
AVI BioPharma, Inc. Receives Major Research and Development Grant From Charley's Fund for Duchenne Muscular Dystrophy
10/15/2007
-
AVI BioPharma, Inc. Drug Demonstrates Strong Survival Benefits and Elimination of Ebola Virus in Animals
9/12/2007
-
AVI BioPharma, Inc. Announces Second Quarter Financial Results
8/8/2007
-
AVI BioPharma, Inc. Announces Refocused Clinical Development Strategy
8/8/2007
-
AVI BioPharma, Inc. Announces 2007 Second Quarter Financial Results Conference Call
8/1/2007
-
AVI BioPharma, Inc. Announces 2007 Second Quarter Financial Results Conference Call
8/1/2007
-
Cook Medical and AVI BioPharma, Inc.: Animal Studies Show Promising Therapeutic Dosing Results Using an Antisense Agent to Treat Heart Disease
7/25/2007
-
AVI BioPharma, Inc. Announces Positive Pre-Clinical Study Results Presented at the 26th Annual Meeting of the American Society for Virology
7/17/2007
-
AVI BioPharma, Inc. Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7/10/2007
-
AVI BioPharma, Inc. Announces First Quarter Financial Results
5/9/2007